These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12552272)

  • 1. The emergence of amphetamine use in New Zealand: findings from the 1998 and 2001 National Drug Surveys.
    Wilkins C; Bhatta K; Casswell S;
    N Z Med J; 2002 Nov; 115(1166):U256. PubMed ID: 12552272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecstasy use in New Zealand: findings from the 1998 and 2001 National Drug Surveys.
    Wilkins C; Bhatta K; Pledger M; Casswell S
    N Z Med J; 2003 Apr; 116(1171):U383. PubMed ID: 12740633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of amphetamine use in New Zealand: findings from the 2001 National Drug Survey.
    Wilkins C; Pledger M; Bhatta K; Casswell S
    N Z Med J; 2004 Mar; 117(1190):U796. PubMed ID: 15107899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent population trends in amphetamine use in New Zealand: comparisons of findings from national household drug surveying in 1998, 2001, and 2003.
    Wilkins C; Sweetsur P; Casswell S
    N Z Med J; 2006 Oct; 119(1244):U2285. PubMed ID: 17072360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006.
    Wilkins C; Sweetsur P
    N Z Med J; 2008 May; 121(1274):61-71. PubMed ID: 18535647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marijuana use in New Zealand, 1990 and 1998.
    Field A; Casswell S
    N Z Med J; 2001 Aug; 114(1137):355-8. PubMed ID: 11587304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine use among Australian workers and its implications for prevention.
    Roche AM; Pidd K; Bywood P; Freeman T
    Drug Alcohol Rev; 2008 May; 27(3):334-41. PubMed ID: 18368616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
    Maxwell JC; Rutkowski BA
    Drug Alcohol Rev; 2008 May; 27(3):229-35. PubMed ID: 18368603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis 'tinny' houses in New Zealand: implications for the use and sale of cannabis and other illicit drugs in New Zealand.
    Wilkins C; Reilly JL; Casswell S
    Addiction; 2005 Jul; 100(7):971-80. PubMed ID: 15955013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who are the new amphetamine users? A 10-year prospective study of young Australians.
    Degenhardt L; Coffey C; Carlin JB; Moran P; Patton GC
    Addiction; 2007 Aug; 102(8):1269-79. PubMed ID: 17624977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired physical health among methamphetamine users in comparison with the general population: the role of methamphetamine dependence and opioid use.
    McKetin R; Kelly E; McLaren J; Proudfoot H
    Drug Alcohol Rev; 2008 Sep; 27(5):482-9. PubMed ID: 18608459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset and lifetime use of drugs in New Zealand: results from Te Rau Hinengaro: the New Zealand Mental Health Survey 2003-2004.
    Wells JE; McGee MA; Baxter J; Agnew F; Kokaua J;
    Drug Alcohol Rev; 2009 Mar; 28(2):166-74. PubMed ID: 19320702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adolescents who have tried illicit drugs and experienced psychiatric symptoms seldom seek professional help. A pilot study of 18-year old high school students in an urban district].
    Gunnarsson M; Fahlke C; Balldin J
    Lakartidningen; 2004 Apr; 101(14):1280-2. PubMed ID: 15101214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation into methamphetamine use: qualitative findings from an exploration of first time use among a group of New Zealand users.
    Sheridan J; Butler R; Wheeler A
    J Psychoactive Drugs; 2009 Mar; 41(1):11-7. PubMed ID: 19455905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal methamphetamine: a source of added sexual risk for Hispanic men who have sex with men?
    Fernández MI; Bowen GS; Warren JC; Ibañez GE; Hernandez N; Harper GW; Prado G
    Drug Alcohol Depend; 2007 Jan; 86(2-3):245-52. PubMed ID: 16930858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of substance use disorders among adolescents who use marijuana and inhalants.
    Wu LT; Pilowsky DJ; Schlenger WE
    Drug Alcohol Depend; 2005 Apr; 78(1):23-32. PubMed ID: 15769554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.